Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

(2016) Bryony Simmons et al.   CLINICAL INFECTIOUS DISEASES

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

(2016) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

Physicians’ Attitudes and Practice Toward Treating Injection Drug Users Infected with Hepatitis C Virus: Results from a National Specialist Survey in Canada

(2016) Angelique Myles et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

(2015) Soumitri Barua et al.   ANNALS OF INTERNAL MEDICINE

EASL Recommendations on Treatment of Hepatitis C 2015

(2015)   JOURNAL OF HEPATOLOGY

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

(2014) N. K. Martin et al.   JOURNAL OF VIRAL HEPATITIS

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

(2014) Peter Ferenci et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

(2014) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history

(2013) Angela Cescon et al.   AIDS

Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs

(2013) Bart P. Grady et al.   CLINICAL INFECTIOUS DISEASES

Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan

(2013) S. A. McDonald et al.   JOURNAL OF VIRAL HEPATITIS

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011

(2013) J. Iversen et al.   JOURNAL OF VIRAL HEPATITIS

Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents

(2013) Maryam Alavi et al.   LIVER INTERNATIONAL

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia

(2012) Margaret E Hellard et al.   MEDICAL JOURNAL OF AUSTRALIA

Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection

(2011) Jason Grebely et al.   HEPATOLOGY

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

(2011) Paul K Nelson et al.   LANCET

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

(2011) Markus Cornberg et al.   LIVER INTERNATIONAL

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study

(2010) Pascal Melin et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Factors to Improve the Management of Hepatitis C in Drug Users: An Observational Study in an Addiction Centre

(2010) Joseph Moussalli et al.   Gastroenterology Research and Practice

Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence

(2009) Margaret Hellard et al.   CLINICAL INFECTIOUS DISEASES

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY